Published in J Clin Oncol on December 01, 1991
Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ (2002) 2.74
Religious struggle and religious comfort in response to illness: health outcomes among stem cell transplant patients. J Behav Med (2005) 1.45
Positive and negative religious coping in German breast cancer patients. J Behav Med (2006) 1.10
Screening for religious/spiritual struggle in blood and marrow transplant patients. Support Care Cancer (2012) 0.82
Spirituality and end-of-life care in disadvantaged men dying of prostate cancer. World J Urol (2010) 0.76
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med (2000) 6.53
Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst (1992) 5.51
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med (1994) 5.03
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med (1994) 3.54
Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer (1998) 3.32
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA (1991) 2.85
Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
Selective retention of dihydrotestosterone by prostatic nuclei. Nature (1968) 2.60
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst (1992) 2.54
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
An international survey of physician attitudes and practice in regard to revealing the diagnosis of cancer. Cancer Invest (1987) 2.49
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
A modified procedure for the determination of leukocyte alkaline phosphatase. Biochem Med (1970) 2.35
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30
Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA (1992) 2.22
Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol (1991) 2.19
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol (2000) 2.13
Use of alternative medicine--a marker for distress? N Engl J Med (1999) 2.13
Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol (1984) 2.12
Characteristics of non-cholera Vibrios isolated from cases of human diarrhoea. Bull World Health Organ (1965) 2.09
Written informed consent in patients with breast cancer. Cancer (1979) 2.01
Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med (1998) 2.01
Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1991) 1.91
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. N Engl J Med (1991) 1.89
Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer (1994) 1.88
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.87
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest (1984) 1.84
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res (1996) 1.82
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
The psychosocial and neuropsychiatric sequelae of the acquired immunodeficiency syndrome and related disorders. Ann Intern Med (1985) 1.75
Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem (1969) 1.74
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med (1989) 1.70
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun (1971) 1.64
Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med (1986) 1.63
Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst (1990) 1.60
Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer. Am J Med (1995) 1.60
The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer (1987) 1.57
Stress and burnout in oncology. Oncology (Williston Park) (2000) 1.56
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med (1995) 1.55
Socioeconomic status and cancer survival. J Clin Oncol (1991) 1.48
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. J Clin Oncol (1994) 1.48
A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group B. Cancer Invest (1994) 1.47
Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol (1992) 1.46
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B. Cancer (1992) 1.44
Depression in hospitalized cancer patients. Psychosom Med (1984) 1.43
Psychotherapy by telephone. A therapeutic tool for cancer patients. Psychosomatics (1991) 1.43
Water-clear cell adenoma of the parathyroid. A case report with immunohistochemistry and electron microscopy. Arch Pathol Lab Med (1995) 1.43
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine. J Clin Oncol (2002) 1.42
Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma. Int J Radiat Oncol Biol Phys (1988) 1.41
Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer (2001) 1.41
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res (1994) 1.39
A national survey of practice patterns in the noninvasive diagnosis of deep venous thrombosis. J Vasc Surg (1999) 1.39
Heart rate adjustment of exercise-induced ST segment depression. Improved risk stratification in the Framingham Offspring Study. Circulation (1991) 1.39
Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992) 1.36
Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol (1994) 1.36
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol (2000) 1.34
Phase I study of phenylacetate administered twice daily to patients with cancer. Cancer (1995) 1.33
Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol (1991) 1.32
Risk of coronary heart disease in subjects with chest discomfort: the Framingham Heart Study. Am J Med (1990) 1.29
Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1992) 1.28
BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res (1999) 1.28
Variation in the response of normal lymphocytes to PHA. Int Arch Allergy Appl Immunol (1969) 1.28
Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues. J Biol Chem (1999) 1.26
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J (1990) 1.24
A brief POMS measure of distress for cancer patients. J Chronic Dis (1987) 1.24
Psychological aspects of anorexia in cancer patients. Cancer Res (1977) 1.24
Quality of life research in oncology. Past achievements and future priorities. Cancer (1991) 1.23
Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience. Horm Res (1996) 1.23
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med (1991) 1.22
Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol (1984) 1.22
A new method for indexing left ventricular mass for differences in body size. Am J Cardiol (1994) 1.21
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study. J Clin Oncol (1998) 1.21
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 1.21
The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis (1971) 1.19
An inherited molecular lesion of erythrocyte pyruvate kinase. Identification of a kinetically aberrant isozyme associated with premature hemolysis. J Clin Invest (1968) 1.19
Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study. JAMA (1989) 1.17
IgE in atopic dermatitis. Arch Dermatol (1971) 1.17
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Involving family members in cancer care: focus group considerations of patients and oncological providers. Psychooncology (2000) 1.15
Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat (1999) 1.15
Complementary DNA encoding human colon cancer manganese superoxide dismutase and the expression of its gene in human cells. Cancer Res (1991) 1.14
The metabolism of IgE. Studies in normal individuals and in a patient with IgE myeloma. J Immunol (1976) 1.13